543943
ASARFI
Start SIP
Invest Now
Start SIP in ASARFI
Asarfi Hospital live price: ₹160.5. It opened at ₹160 vs previous close ₹162; intraday high/low: ₹164/₹155. The 50 & 200 DMA stand at ₹170.24/₹153.35.
Asarfi Hospital Performance
- Low
- ₹155
- High
- ₹164
- 52 Week Low
- ₹73
- 52 Week High
- ₹221
- Open Price₹160
- Previous Close₹162
- Volume139,000
- 50 DMA₹170.24
- 100 DMA₹167.44
- 200 DMA₹153.35
Investment Returns
- Over 1 Month -13.2%
- Over 3 Month -17.69%
- Over 6 Month + 9.18%
- Over 1 Year + 84.48%
Smart Investing Starts Here Start SIP with Asarfi Hospital for Steady Growth!
Asarfi Hospital Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 29.9
- PEG Ratio
- 0.2
- Market Cap Cr
- 316
- P/B Ratio
- 3.4
- Average True Range
- 7.75
- EPS
- -
- Dividend Yield
- 0
- MACD Signal
- -3.62
- RSI
- 40.51
- MFI
- 37.32
Asarfi Hospital Financials
Asarfi Hospital Technicals
EMA & SMA
Current Price
₹160.50
-1.5
(-0.93%)
- Bearish Moving Average 14
- Bullish Moving Average 2
- 20 Day
- ₹165.59
- 50 Day
- ₹170.24
- 100 Day
- ₹167.44
- 200 Day
- ₹153.35
Resistance and Support
159.38
- R3 172.27
- R2 167.88
- R1 163.77
- S1 155.27
- S2 150.88
- S3 146.77
Asarfi Hospital Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-02-09 | Quarterly Results | |
| 2025-08-20 | A.G.M. | |
| 2025-08-07 | Quarterly Results | |
| 2025-05-08 | Audited Results | |
| 2025-01-31 | Quarterly Results |
Asarfi Hospital F&O
About Asarfi Hospital
- NSE Symbol
- ASARFI
- BSE Symbol
- 543943
- Managing Director
- Mr. Udai Pratap Singh
- ISIN
- INE0DN001027
Similar Stocks to Asarfi Hospital
Asarfi Hospital FAQs
Asarfi Hospital share price is ₹160 As on 13 March, 2026 | 03:52
The Market Cap of Asarfi Hospital is ₹315.8 Cr As on 13 March, 2026 | 03:52
The P/E ratio of Asarfi Hospital is 29.9 As on 13 March, 2026 | 03:52
The PB ratio of Asarfi Hospital is 3.4 As on 13 March, 2026 | 03:52
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.